Industry News

Researchers at Monash University and the Hudson Institute have developed an exosome therapy to treat IPF and formed the spinout company Regenasome. Exosomes are nano-vesicles...

Financing round significantly oversubscribed by both new and existing investors Proceeds enable advancement of our exosome therapeutics into the clinic and expansion of our world-leading exosome...

Ciloa, a pioneer company specialized in the in vivo customization of exosomes, announced today the selection of its project as part of the “Sanofi iTech Awards” program. It is the first time that this program has selected innovative projects led by biotechnology companies. ...

VivaZome Therapeutics and La Trobe University announced that they have entered into a new collaborative research project focused on developing novel exosome therapeutics. Under the collaborative arrangement, VivaZome scientists will work alongside members of Professor Andrew Hill’s laboratory in the ...

Codiak BioSciences, a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics a...

The exosome field has gone through a rapid growth phase in parallel with the increasing attention over the potential of liquid biopsies. Despite recent progress of liquid biopsies for late-stage cancers, there remains a need to improve both the accuracy ...

Cytiva launches the “Exosome Challenge,” an industry challenge to overcome hurdles in exosome production and manufacturing. The challenge will...

The FDA has granted Organicell Regenerative Medicine permission to begin a clinical trial testing the company’s lead product, Zofin, in people with chronic obstructive pulmonary disease...

The expanded Access Program provides a pathway for patients to gain access to treatment with ExoFlo outside of the active Phase II research clinical trial. Direct Biologics, announced today that the first patient has been treated under its expanded access ...

Capricor Therapeutics, a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class cell- and exosome-based therapeutics for the treatment and...